Trelegy Ellipta Interactions
There are 540 drugs known to interact with Trelegy Ellipta (fluticasone/umeclidinium/vilanterol), along with 13 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 55 are major, 466 are moderate, and 19 are minor.
- View all 540 medications that may interact with Trelegy Ellipta
- View Trelegy Ellipta alcohol/food interactions (2)
- View Trelegy Ellipta disease interactions (13)
Most frequently checked interactions
View interaction reports for Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- carvedilol
- doxycycline
- Eliquis (apixaban)
- famotidine
- fluticasone nasal
- furosemide
- gabapentin
- hydrochlorothiazide
- levothyroxine
- lisinopril
- losartan
- metformin
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- montelukast
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- rosuvastatin
- Singulair (montelukast)
- tamsulosin
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Trelegy Ellipta alcohol/food interactions
There are 2 alcohol/food interactions with Trelegy Ellipta (fluticasone / umeclidinium / vilanterol).
Trelegy Ellipta disease interactions
There are 13 disease interactions with Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) which include:
- milk protein allergies
- cardiovascular
- diabetes
- hypokalemia
- seizures
- anticholinergic effects
- hepatic impairment
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
- severe liver impairment
Report options
More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Trelegy Ellipta consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (259)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: bronchodilator combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Anoro Ellipta
Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
